Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancer.
Pantuck
A J
AJ
Belldegrun
A S
AS
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D015316:Genetic Therapy; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics* / Q000627:therapeutic use*; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000628:therapy*
D000970:Antineoplastic Agents; D007376:Interleukin-2